Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1979 July; 72(7): 513–519.
PMCID: PMC1436964

Antiplatelet agents: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1005K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Acheson J, Danta G, Hutchinson EC. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J. 1969 Mar 8;1(5644):614–615. [PMC free article] [PubMed]
  • Acheson J, Hutchinson EC. Controlled trial of clofibrate in cerebral vascular disease. Atherosclerosis. 1972 Mar-Apr;15(2):177–183. [PubMed]
  • Arrants JE, Hairston P. Use of Persantine in preventing thromboembolism following valve replacement. Am Surg. 1972 Aug;38(8):432–435. [PubMed]
  • Dyken ML, Kolar OJ, Jones FH. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy. Stroke. 1973 Sep-Oct;4(5):732–736. [PubMed]
  • Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436–440. [PMC free article] [PubMed]
  • Evans G. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia. Surg Forum. 1972;23(0):239–241. [PubMed]
  • Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977 May-Jun;8(3):301–314. [PubMed]
  • Gent AE, Brook CG, Foley TH, Miller TN. Dipyridamole: a controlled trial of its effect in acute myocardial infarction. Br Med J. 1968 Nov 9;4(5627):366–368. [PMC free article] [PubMed]
  • Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246–1249. [PubMed]
  • Harrison MJ, Marshall J, Meadows JC, Russell RW. Effect of aspirin in amaurosis fugax. Lancet. 1971 Oct 2;2(7727):743–744. [PubMed]
  • Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M. The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation. 1975 Sep;52(3):497–499. [PubMed]
  • Steele P, Battock D, Genton E. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Circulation. 1975 Sep;52(3):473–476. [PubMed]
  • Steele P, Carroll J, Overfield D, Genton E. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks. Stroke. 1977 May-Jun;8(3):396–398. [PubMed]
  • Steele P, Ellis JH, Jr, Weily HS, Genton E. Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation. 1977 Apr;55(4):660–661. [PubMed]
  • Steele PP, Weily HS, Davies H, Genton E. Platelet survival in patients with rheumatic heart disease. N Engl J Med. 1974 Mar 7;290(10):537–539. [PubMed]
  • Steele P, Weily H, Davies H, Ppppas G, Genton E. Platelet survival time following aortic valve replacement. Circulation. 1975 Feb;51(2):358–362. [PubMed]
  • Steele PP, Weily HS, Genton E. Platelet survival and adhesiveness in recurrent venous thrombosis. N Engl J Med. 1973 May 31;288(22):1148–1152. [PubMed]
  • Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med. 1971 Jun 24;284(25):1391–1394. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press